Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review
- 18 November 2006
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 166 (4) , 365-376
Abstract
Recurrent acute respiratory tract infections (ARTI) are a common problem in childhood. Some evidence suggests a benefit regarding the prevention of ARTI in children treated with the immunomodulator OM-85 BV (Bronchovaxom).Keywords
This publication has 20 references indexed in Scilit:
- Oral Purified Bacterial Extracts in Chronic Bronchitis and COPDChest, 2004
- Use of om-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levelsAllergologia et Immunopathologia, 2003
- Safety and Efficacy of Two Courses of OM-85 BV in the Prevention of Respiratory Tract Infections in Children During 12 MonthsChest, 2001
- Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: A double-masked, placebo-controlled clinical trialClinical Therapeutics, 2000
- Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis MediaNew England Journal of Medicine, 1999
- Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centersThe Pediatric Infectious Disease Journal, 1993
- IgG subclass deficiency in children with recurrent bronchitisEuropean Journal of Pediatrics, 1992
- Immunotherapy with an Oral Bacterial Extract (OM-85 BV) for Upper Respiratory InfectionsRespiration, 1991
- Broncho-Vaxom® in Children with Rhinosinusitis: A Double-Blind Clinical TrialORL, 1988
- Clinical and immunobiological effects of an orally administered bacterial extractInternational Journal of Immunopharmacology, 1984